RB1 Genetic Alterations in Estrogen Receptor–Positive Breast Carcinomas: Correlation With Neuroendocrine Differentiation

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute (P30-CA008748, P50 CA24779 01)
  • National Institutes of Health
  • eFFECTOR Therapeutics
  • AstraZeneca
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology
  • Cycle for Survival
  • Goldman Sachs
  • Breast Cancer Research Foundation

This publication has 35 references indexed in Scilit: